Zerodha’s Nithin Kamath Flags ULIP, Endowment Traps; Says Health Policies Remain Complex
Nithin Kamath, the founder of India’s largest stockbroker Zerodha, has once again drawn attention to common financial mistakes made by Indian investors. In a recent social media post, Kamath pointed out that many people continue to buy Unit Linked Insurance Plans (ULIPs) and endowment plans. He said this happens even when enough information is available to avoid these products. Kamath called these choices “persistent personal finance blunders.”
Kamath noted that these financial mistakes have not changed much over the years. He said there is a lack of innovation in the way Indians make poor financial decisions. The core problem, according to him, is that insurance and investment are wrongly combined in products like ULIPs and endowment plans. These products try to do two things at once. But they often do neither very well. Investors end up paying high fees and getting low returns.
Why ULIPs and Endowment Plans Are Problematic
ULIPs and endowment plans are sold as a way to save money and get life insurance at the same time. But experts like Kamath argue that this mix is inefficient. A ULIP invests part of your premium in market-linked funds. But it also charges high fees for insurance and management. Over time, these fees eat into your returns. Endowment plans are similar. They offer a guaranteed payout after a fixed period. But the returns are usually lower than what you can get from simple investments like mutual funds or fixed deposits.
For example, imagine you buy a ULIP with a premium of Rs 1 lakh per year. A big portion of that money goes towards insurance costs and administrative charges. Only the remaining amount is actually invested. In contrast, if you buy a pure term insurance plan separately, the premium is very low. You can then invest the rest of your money in a low-cost mutual fund. This approach often gives you better returns and more flexibility.
Kamath said that these bundled products are easier to scrutinize than health insurance policies. He argued that because ULIPs and endowment plans are simpler to understand, poor choices are harder to excuse. Investors can easily compare fees, returns, and benefits. Yet many still choose these products without proper research.
Health Insurance Remains Complex
While Kamath criticized ULIPs and endowment plans, he also acknowledged that health insurance is a different story. Health insurance policies in India are still very complex. They have many terms, conditions, and exclusions. It is hard for a common person to compare plans and understand what is covered. Kamath said this complexity makes it difficult for investors to make smart choices in health insurance.
For instance, a health insurance policy might exclude pre-existing diseases for the first few years. It might also have sub-limits on room rent or specific treatments. These details are often hidden in fine print. As a result, many people buy health insurance without fully understanding what they are getting. Kamath suggested that regulators and insurers need to simplify health insurance products. This would help consumers make better decisions.
What Investors Should Do
Kamath’s message is clear. Investors should avoid mixing insurance and investment. Buy a pure term insurance plan for life cover. It is cheap and simple. Then invest the rest of your money in low-cost options like index funds or fixed deposits. For health insurance, take time to read the policy document. Compare plans from different companies. Look for a plan with high coverage, low waiting periods, and fewer exclusions.
In summary, Nithin Kamath has highlighted two key issues. First, Indians continue to make the same old mistakes with ULIPs and endowment plans. Second, health insurance remains a confusing product. By understanding these traps, investors can make smarter choices and protect their financial future.
